PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Living Drug' against tough prostate cancer
Disease control Recruiting nowThis is an early safety study testing a new cell therapy for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. Doctors will collect and modify a patient's own immune cells (NK cells) to target a protein on the cancer, then in…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New immune cell attack tested for tough prostate cancer
Disease control Recruiting nowThis early-stage study is testing a new type of immunotherapy for men with advanced prostate cancer that has stopped responding to standard hormone treatments. Doctors are using specially engineered immune cells, called CAR-NK cells, designed to find and kill prostate cancer cell…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New weapon tested in fight against tough cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cancer drug called MBRC-201 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the body processes the drug. The study will en…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC